Here, ITIH3 levels were not significantly elevated compared to HCs, but were similar to levels seen in PASS-positive anti-AChR-Ab-positive MG patients (Fig. 4a; Suppl. This evidence concerns the gene ITIH3 and myasthenia gravis.